Inflammatory skin conditions

Got Itch?
Itch is a symptom felt across inflammatory skin conditions you are not alone

Atopic dermatitis

Atopic dermatitis is a common chronic, non-communicable skin disease characterized by dry skin, localized red scaly patches, and intense itching as well as skin pain. Atopic dermatitis is also known as ‘atopic eczema’, ‘neurodermatitis’, or just simply as ‘eczema.

  •  The prevalence of atopic dermatitis or eczema is high, affecting up to 20% of children and up to 10% of adults, with the main burden in children.  About 223 million people are living with atopic dermatitis as of 2022 around 43 million are aged one to four.  
  • The associated burden of disease can have a significant impact on a person’s physical well-being and quality of life.  
  • The intensity of the itch experienced can result in repeated scratching of the skin to relieve the itch, often leading to more skin damage, and more itch (known as the itch-scratch-itch cycle).

Skin conditions impact the physical and psychological well-being of patients of all ages and care protocols can often entail repeated office visits and time-consuming therapies that are difficult to integrate into compliance and make many inflammatory skin diseases difficult to treat.

Psoriasis Vulgaris

Psoriasis is an immune-mediated disease (a disease with an unclear cause that is characterized by inflammation caused by dysfunction of the immune system) that causes inflammation in the body. There may be visible signs of inflammation such as raised plaques and scales on the skin1.   

  • Around 125 million people are affected by psoriasis worldwide and studies show that 75% of patients are dissatisfied with their treatment. 
  • Nearly 60 percent of people with psoriasis reported their disease to be a large problem in their everyday life. Psoriasis has a greater impact on the quality of life in women and younger patients. 

 Blue LED Therapy,
is an innovative way to treat
inflammatory skin conditions without the use of drugs or UV radiation.

This post is also available in: Dutch German